JAZZ (Jazz Pharma) Net earnings per share (EPS TTM)

Jazz Pharma (JAZZ) - corporate logo

Jazz Pharmaceuticals maintains a positive outlook driven by its stable authority in sleep therapy, although the annual EPS TTM growth rate on the GURU.Markets chart exhibits volatility. This is driven by the threat of patent expirations and generic pressure, as well as fierce competition in neurobiology necessitating costly deals. The current value of 160.90 indicates the status of earnings relative to the company's multi-year cycles.

Jazz Pharma - JAZZ Earnings per share for the last twelve months (period 02/11/2024 - 11/17/2026)

JAZZ (Jazz Pharmaceuticals PLC): analytical breakdowns and indicator data

- price and consensus price forecast:
Fundamental company valuation:JAZZ Jazz Pharma
Flagship merchandise of Jazz Pharmaceuticals plc

For Jazz Pharmaceuticals (JAZZ), which is investing in the environmental modernization of its plants, the relative YoY EPS growth over the last 12 months serves as an indicator of cost management efficiency amid rising profits. This metric measures the percentage change in net income per share on a rolling annual basis, allowing for an assessment of the company's real income and capital resilience under tight monetary policy.

Direct competitors

Net earnings per one share for the last twelve months Cytokinetics Inc|PTCT (PTC Therapeutics Inc) - Net earnings per share for the last 12 months|Scholar Rock Inc. (SRRK) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Centessa Pharmaceuticals|Net earnings per one share for the last twelve months dyne-tx.com DYN|Earnings per share for the last twelve months Edgewise Corp (EWTX)|RAPP - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months Alumis Corp ALMS|Zevra Corp - Earnings per share for the last twelve months|CTNM - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Larimar Therapeutics|CAPR: Net earnings per share (EPS TTM)|Net earnings per share for the trailing year Entrada TRDA|Net earnings per share for the last 12 months PTHS|Net earnings per one share for the last twelve months medicinova.com MNOV|Net earnings per share (EPS TTM) SER|Earnings per share for the last twelve months BTAI (BioXcel Therapeutics)|Earnings per share for the last twelve months ProMIS Neurosciences, Inc. PMN|APUS (Apimeds) - Earnings per one share for the last 12 months|AEON - Earnings per share for the last twelve months|Net earnings per share for the last four quarters NLS Pharmaceutics Ltd. NLSP|Bionomics Limited (BNOX) - Earnings per share for the last twelve months|fsdpharma.com - Earnings per share for the trailing year|RETA (reatapharma.com) - Net earnings per share (EPS TTM)